Voleon Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Sell
9,266
-45,734
-83% -$4.97M 0.03% 412
2026
Q1
$5.08M Sell
55,000
-1,689
-3% -$170K 0.11% 194
2025
Q4
$5.79M Buy
+56,689
New +$5.07M 0.12% 188

Other funds holding GH

Voleon Capital Management's GH Position: Q2 2026 in Review

Voleon Capital Management reduced its Guardant Health (GH) stake by 83% in Q2 2026, selling an estimated $4.97M and leaving 9,266 shares worth $1.39M. The position accounts for 0.03% of the portfolio, ranked #412.

Voleon Capital Management first reported a position in GH in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.79M in Q4 2025. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Voleon Capital Management held 9,266 shares of Guardant Health worth $1.39M as of Q2 2026.
  • Voleon Capital Management sold 45,734 Guardant Health shares in Q2 2026, an estimated $4.97M.
  • Guardant Health made up 0.03% of Voleon Capital Management's portfolio in Q2 2026, its #412 holding.
  • Voleon Capital Management first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
  • Voleon Capital Management's Guardant Health position peaked at $5.79M in Q4 2025.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.